Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans

I Wessler, CJ Kirkpatrick, K Racké - Pharmacology & therapeutics, 1998 - Elsevier
Acetylcholine acts as a neurotransmitter in the central and peripheral nervous systems in
humans. However, recent experiments demonstrate a widespread expression of the …

Alternative mechanisms for tiotropium

…, NJ Gross, JA Nadel, M Pfeifer, K Racké… - Pulmonary …, 2009 - Elsevier
Tiotropium is commonly used in the treatment of chronic obstructive pulmonary disease.
Although largely considered to be a long-acting bronchodilator, its demonstrated efficacy in …

Control by cholinergic mechanisms

K Racké, UR Juergens, S Matthiesen - European journal of pharmacology, 2006 - Elsevier
… Muscarinic agonists were shown to exert inhibitory effects on calcium activated potassium
channels (K ca ) and thereby oppose hyperpolarizing (ie, relaxant) stimuli. This effect involves …

Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man

…, KD Höhle, M Schemann, K Racké… - Naunyn-Schmiedeberg's …, 1997 - Springer
Acetylcholine acts as a prominent transmitter in the central and peripheral nervous system.
The aim of the present study was to investigate whether mammalian non-neuronal cells can …

Inhibitory activity of 1, 8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes

UR Juergens, T Engelen, K Racké, M Stöber… - Pulmonary …, 2004 - Elsevier
BACKGROUND:: The therapeutic value of secretolytic agents in COPD and asthma is still
disputed. For this reason, in a preclinical study we aimed to test the potential anti-inflammatory …

Regulation of serotonin release from the intestinal mucosa

K Racké, H Schwörer - Pharmacological research, 1991 - Elsevier
… Schw6rer H, Racks K, Kilbinger H. Effect of vasoactive intestinal polypeptide on the release
… Schw6rer H, Rack6 K. Effects of cisplatin on the release of 5-hydroxytryptamine from guinea-…

Increased arginase activity in cystic fibrosis airways

…, R Schwiertz, S Matthiesen, K Racké… - American journal of …, 2005 - atsjournals.org
Rationale: Airway nitric oxide concentrations are reduced in cystic fibrosis (CF). Arginases
compete for L-arginine, the substrate of nitric oxide synthesis. Objectives: We hypothesized …

Inhibition of arginase by in alveolar macrophages: implications for the utilization of l‐arginine for nitric oxide synthesis

…, H Nematollahi, C Hey, R Busse, K Racké - FEBS …, 1995 - Wiley Online Library
… Provided that the K m values and total activities of NO synthase and arginase are comparable,
the two enzymes may compete for the endogenous c-arginine, the availability of which …

Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor

…, J Klöckner, C Dallanoce, K Racké… - British journal of …, 2013 - Wiley Online Library
Background and Purpose Artificial agonists may have higher efficacy for receptor activation
than the physiological agonist. Until now, such ‘superagonism’ has rarely been reported for …

Inhibition of arginase in rat and rabbit alveolar macrophages by Nω‐hydroxy‐D,L‐indospicine, effects on L‐arginine utilization by nitric oxide synthase

…, G Ketterer, I Wessler, K Racké - British journal of …, 1997 - Wiley Online Library
Alveolar macrophages (AMΦ) exhibit arginase activity and may, in addition, express an
inducible form of nitric oxide (NO) synthase (iNOS). Both pathways may compete for the substrate…